Deep brain stimulation, or DBS, technology has the ability to smooth out abnormalities in neurological signals that are linked to movement disorders like Parkinson’s disease and essential tremor—but ...

EDINBURGH, Scotland, Sept. 26, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the GUIDE™ XT System for visualization of Deep Brain Stimulation (DBS) in ...

GUIDE DBS is the World's First Deep Brain Stimulation Visual Simulation System NATICK, Mass., Boston Scientific Corporation has received CE Mark approval for use of the GUIDE™ DBS System, the world's ...

Boston Scientific, Inc. BSX recently obtained a CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology. When used as an element of the Vercise Genus Deep Brain Stimulation (DBS ...

Medical technology, services and solutions major, Medtronic plcMDT continues to expand its brain therapy business worldwide. As a major breakthrough, the company recently announced the receipt of ...

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is used for advanced Parkinson’s disease treatment to improve the quality of life of patients by alleviating motor symptoms, as well as ...

Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...

Tardive dyskinesia (TD) can be addressed by the right intervention even in severe, refractory cases. These cases, characterized by involuntary muscle movements, are most often caused by antipsychotics ...

Boston Scientific Corporation BSX has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians ...